We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Reducing Risk, Boosting Compliance in Clinical Trials
Reducing Risk, Boosting Compliance in Clinical Trials
January 12, 2012
Concerned about the length of time it takes to get cancer trials from concept to initiation, the National Cancer Institute (NCI) set target time frames and drop-dead points for trials it funds.